LEUKEMIA-CUTIS IN ACUTE PROMYELOCYTIC LEUKEMIA - REPORT OF 3 CASES AFTER TREATMENT WITH ALL-TRANS-RETINOIC ACID

被引：41
作者：
GIRALT, S
OBRIEN, S
WEEKS, E
LUNA, M
KANTARJIAN, H
机构：
[1] Departments of Hematology and Pathology, University of Texas, M.D. Anderson Cancer Center, Houston, TX 60637
来源：
LEUKEMIA & LYMPHOMA | 1994年 / 14卷 / 5-6期
关键词：
LEUKEMIA CUTIS; APL; PROMYELOCYTIC LEUKEMIA; ALL-TRANS RETINOIC ACID;
D O I：
10.3109/10428199409049703
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Acute promyelocytic leukemia (APL) is a distinct form of acute myelogenous leukemia characterized by an abundant number of abnormal progranulocytes, a severe coagulopathy and a distinct chromosomal abnormality t(15;17). Recently all-trans retinoic acid (ATRA) has been shown to induce complete remissions in APL. We report three patients with APL treated with ATRA, who at the time of relapse had leukemic infiltration of the skin (leukemia cutis), a manifestation which we had not seen previously in over 60 patients with APL treated with chemotherapy alone and has only rarely been reported in the literature. We hypothesize that ATRA treatment for APL may be associated with an increased incidence of extramedullary disease at the time of relapse, which may be mediated through an increase in expression of adhesion molecules. Careful observation for extramedullary relapses in patients treated with ATRA for APL will be needed to confirm our observation.
引用
收藏
页码：453 / 456
页数：4
相关论文
共 21 条
  • [1] Hillestad L.K., Acute promyelocyte leukemia, Acta Med. Scand., 159, pp. 189-194, (1957)
  • [2] Larson P., Kondo K., Vardiman J., Butler A., Golomb H., Rowley J., Evidence for a 15
  • [3] 17 translocation in every patient with acute promyelocytic leukemia, Am. J. Med., 76, pp. 827-841, (1984)
  • [4] Huang M.E., Ye Y.C., Chen S.R., Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia, Blood, 72, pp. 567-572, (1988)
  • [5] Borrow J., Goddard Sheer A.D., Solomon E., Molecular analysis of acute promyelocytic leukemia breakpoint cluster region on chromosome 17, Science, 249, pp. 1577-1580, (1990)
  • [6] de The Chomienne H., Lamotte C.M., Degos L., De-Jean A., The t(15,17) translocation of acute promyelocytic leukemia fuses the retinoic acid receptor-a gene to a novel transcribed locus, Nature, 347, pp. 558-561, (1990)
  • [7] Castaigne C., Chomienne C., Fenaux P., Daniel M., Degos L., Hyperleukocytosis during all-trans retinoic acid therapy for acute promyelocytic leukemia, Blood, 76, (1990)
  • [8] Frankel S., Eardley A., Lauwers G., The “Retinoic Acid Syndrome” in acute promyelocytic leukemia, Ann. Intern. Med., 117, pp. 292-296, (1992)
  • [9] Kantarjian H., Keating M., Walters R., Estey E., McCredie K., Smith T., Dalton W., Cork A., Trujillo J., Freireich E., Acute promyelocytic leukemia. M.D. Anderson Hospital experience, Am. J. Med., 80, pp. 789-796, (1986)
  • [10] Barcos M., Lane W., Gomez G., Han T., Freeman A., Preisler H., Henderson E., An autopsy study of 1206 acute and chronic leukemias (1958 to 1982), Cancer, 60, pp. 827-837, (1987)
123